A nationwide epidemiologic study of breast cancer incidence following breast reduction surgery in a large cohort of Swedish women

Breast Cancer Research and Treatment

Volumn 97, Issue 2, 2006, Pages 131-134

  Fryzek, Jon P ^a,b   Ye, Weimin ^c   Nyrén, Olof ^c   Tarone, Robert E ^a   Lipworth, Loren ^a,b   McLaughlin, Joseph K ^a  

^a INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast cancer; Breast reduction surgery; Cohort; Epidemiology

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST REDUCTION; BREAST SURGERY; CANCER INCIDENCE; CANCER PATIENT; COHORT ANALYSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROPHYLAXIS; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAMMAPLASTY; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN;

EID: 33646574618     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-005-9099-2     Document Type: Article

References (25)

1. Meijers-Heijboer H, van Geel B, van Putten WLJ, et al.: Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med 345: 159-164, 2001
2. Hartmann LC, Schaid DJ, Woods JE, et al.: Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med 340: 77, 1999
3. Hartmann LC, Sellers TA, Schaid DJ, et al.: Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst 93: 1633-1637, 2001
4. McDonnell SK, Schaid DJ, Myers JL, et al.: Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19: 3938-3943, 2001
5. van Roosmalen MS, Verhoef LCG, Stalmeier PFM, Hoogerbrugge N, van Daal WAJ: Decision analysis of prophylactic surgery or screening for BRCA1 mutation carriers: a more prominent role for oophorectomy. J Clin Oncol 20: 2092-2100, 2002
6. Roukos DH, Agnanti NJ, Paraskevaidis E, Kappas AM: Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations. Ann Surg Oncol 9: 941-943, 2002
7. Frost MH, Schaid DJ, Sellers TA, et al.: Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. JAMA 284: 319-324, 2000
8. Eisen A, Weber BL: Prophylactic mastectomy: the price of fear. N Engl J Med 340: 137-138, 1999
9. Swanson GP: Re: risk reduction mastectomy: clinical issues and research needs (Letter). J Natl Cancer Inst 94: 143-144, 2002
10. Stefanek M, Hartmann L, Nelson W: Re: risk reduction mastectomy: clinical issues and research needs (Reply). J Natl Cancer Inst 94: 143-144, 2002
11. Tarone RE, Lipworth L, Young VL, McLaughlin JK: Breast reduction surgery and breast cancer risk: does reduction mammoplasty have a role in primary prevention strategies for women at high risk of breast cancer?. Plast Reconstr Surg 113: 2104-2110, 2004
12. Wells SA, Jr., Young VL, Andriole DA: Atlas of Breast Surgery. Mosby, St. Louis, Mo, 1994, 295-320
13. Chadbourne EB, Zhang S, Gordon MJ, et al.: Clinical outcomes in reduction mammaplasty: a systematic review and meta-analysis of published studies. Mayo Clin Proc 76: 503-510, 2001
14. Lund K, Ewertz M, Schou G: Breast cancer incidence subsequent to surgical reduction of the female breast. Scand J Plast Reconstr Hand Surg 21: 209, 1987
15. Baasch M, Nielsen SF, Engholm G, Lund K: Breast cancer incidence subsequent to surgical reduction of the female breast. Br J Cancer 73: 961-963, 1996
16. Brinton L, Malone KE, Coates RJ, et al.: Breast enlargement and reduction: results from a breast cancer case-control study. Plast Reconstr Surg 97: 269-275, 1996
17. Boice JD, Friis S, McLaughlin JK, et al.: Cancer following breast reduction surgery in Denmark. Cancer Causes Control 8: 253-258, 1997
18. Brown MH, Weinberg M, Chong N, Levine R, Holowaty E: A cohort study of breast cancer risk in breast reduction patients. Plast Reconstr Surg 103: 1674-1681, 1999
19. Boice JD, Persson I, Brinton L, et al.: Breast cancer following breast reduction surgery in Sweden. Plast Reconstr Surg 106: 755-762, 2000
20. Brinton LA, Persson I, Boice JD, McLaughlin JK, Fraumeni JF, Jr.: Breast cancer risk in relation to amount of tissue removed during breast reduction operations in Sweden. Cancer 91: 478-483, 2001
21. Swedish National Board of Health and Welfare. The Swedish hospital discharge register. Epidemiology Center. (Web-site assessed April 6, 2005, at http://www.sos.se/epc/english/ParEng.htm)
22. Bailar JC III, Ederer F: Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 20: 639-643, 1964
23. Franceschi S: Breast size, breast reduction, and cancer risk. Cancer Causes Control 8(2): 125-126, 1997
24. Fryzek JP, Weiderpass E, Signorello LB, Hakelius L, Lipworth L, Blot WJ, McLaughlin JK, Nyren O: Characteristics of women with cosmetic breast augmentation surgery compared with breast reduction surgery patients and women in the general population of Sweden. Ann Plast Surg. 45(4): 349-356, 2000
25. Modesitt SC, van Nagell JR Jr.: The impact of obesity on the incidence and treatment of gynecologic cancers: a review. Obstet Gynecol Surv. 60(10): 683-692, 2005 (October)